Procurement News Notice |
|
| PNN | 5557 |
| Work Detail | Benchmark Initiates Coverage on Cantel Medical Corp. The shares have been rated Buy. The rating by Benchmark was issued on Aug 29, 2016. In a different note, Needham said it Initiates Coverage on Cantel Medical Corp., according to a research note issued on Aug 24, 2016. The shares have been rated ‘Hold’ by the firm. Cantel Medical Corp. (CMN) made into the market gainers list on Thursdays trading session with the shares advancing 0.45% or 0.34 points. Due to strong positive momentum, the stock ended at $75.95, which is also near the day’s high of $76.09. The stock began the session at $75.81 and the volume stood at 1,52,289 shares. The 52-week high of the shares is $76.09 and the 52 week low is $47.76. The company has a current market capitalization of $3,167 M and it has 4,17,01,975 shares in outstanding. Cantel Medical Corp.(CMN) last announced its earnings results on Jun 8, 2016 for Fiscal Year 2016 and Q3.Company reported revenue of $173.70M. Analysts had an estimated revenue of $163.16M. Earnings per share were $0.44. Analysts had estimated an EPS of $0.36. Several Insider Transactions has been reported to the SEC. On Jun 21, 2016, Jorgen B Hansen (President and COO) sold 2,000 shares at $72.44 per share price.Also, On Jun 14, 2016, Eric W Nodiff (EVP and General Counsel) sold 2,574 shares at $72.97 per share price.On Jun 14, 2016, Mark N. Diker (director) sold 7,000 shares at $73.30 per share price, according to the Form-4 filing with the securities and exchange commission. Cantel Medical Corp. is a provider of infection prevention and control products and services in the healthcare market. The Company’s segments include Endoscopy Water Purification and Filtration Healthcare Disposables Dialysis and Specialty Packaging. Its Endoscopy segment includes medical device reprocessing systems disinfectants detergents and other supplies. The Company’s Water Purification and Filtration segment includes water purification equipment and services filtration and separation products and disinfectants sterilization and decontamination products and services. Its Healthcare Disposables segment includes single-use infection prevention and control healthcare products. The Company’s Dialysis segment includes medical device reprocessing systems sterilants/disinfectants and dialysate concentrates. Its Specialty Packaging segment includes specialty packaging and thermal control products as well as related compliance training. |
| Country | United States , Northern America |
| Industry | Financial Services |
| Entry Date | 15 Oct 2016 |
| Source | http://www.thefoundersdaily.com/benchmark-initiates-coverage-on-cantel-medical-corp-to-buy/663453/ |
